Proactive Investors - Run By Investors For Investors

OptiBiotix Health - the commercial momentum continues to build

After a string of deals for its health products, including one earlier this week, the company said it had inked an exclusive agreement in Poland
pic of a man measuring his waist
“This is the first step in taking OptiBiotix's own label GoFigure products to international markets," said sales and marketing director, Christina Wood

The commercial momentum at OptiBiotix Health PLC (LON:OPTI) continues to build.

After a string of deals for its health products, including one earlier this week, the company said it had inked an exclusive agreement in Poland.

The tie-up gives local operator Extensor the rights to distribute OptiBiotix’s GoFigure weight management line across the country.

Sales and marketing director, Christina Wood, said: “This is the first step in taking OptiBiotix's own label GoFigure products to international markets.

“This increases brand recognition and value in addition to creating a demand for SlimBiome, the functional ingredient within GoFigure products.

“This means we are able to derive revenue from both the sale of our own brand GoFigure products and SlimBiome."

Focused on the human microbiome, OptiBiotics has developed a series of products and potential treatments focused on changing the gut flora to tackle obesity, high cholesterol and diabetes.

View full OPTI profile View Profile

OptiBiotix Health PLC Timeline

Related Articles

LX2 analyzer
May 07 2019
Armed with promising study results and proven technology, LexaGene is getting ready to launch the LX2 Genetic Analyzer to underserved markets valued at an estimated US$40 billion
harley street
May 10 2019
Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020
Social media use
April 18 2019
Social first has allowed sites like UNILAD to amass a huge audience with very little capital injection, but what is social first publishing and how is it changing the nature of content and advertising?

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use